Dr. Reddy's Laboratories Limited
NYSEDr. Reddy's Laboratories heads into today's June 17 earnings release with the same structural tension that has defined this entire preview cycle — but the borrow market has tightened sharply since the June 13 article, adding a new layer to an already charged setup. The headline development since the last preview is in availability, which has fallen back to 41.6% from 86% on June 11…
Dr. Reddy's Laboratories heads into today's June 17 earnings release with the same structural tension that has defined this entire preview cycle — but the borrow market has tightened sharply since the June 13 article,…
Dr. Reddy's Laboratories arrives at its June 16 earnings release with the defining feature of this preview cycle now more pronounced than at any prior print: the short position has broken out to a new high, even as…
Snapshot as of 21 Jun 2026
Dr. Reddy's Laboratories arrives at its June 10 print with the same structural split that has defined this entire preview cycle — but the lending market has shifted materially since the last article. The most notable…
Dr. Reddy's Laboratories carries the same structural divide into its June 9 print that has defined this entire preview cycle — short sellers sitting near their highs, options traders showing no concern whatsoever. The…
Dr. Reddy's Laboratories arrives at its June 5 earnings release carrying the same stubborn split that has defined this entire preview cycle — though the data has shifted under both camps since yesterday's article. The…
Dr. Reddy's Laboratories reaches its June 3 earnings release with the same structural divide that has defined this entire preview cycle — short sellers entrenched near cycle highs, options traders resolutely…
Dr. Reddy's Laboratories heads into its June 2 results with the same structural divide that has run through this entire preview cycle — short sellers still elevated, options traders still unbothered — though the short…
Dr. Reddy's Laboratories approaches its June 1 earnings release with the same stubborn divergence that has defined this entire preview cycle — but the data has shifted under both camps since yesterday's article. Short…
Dr. Reddy's Laboratories arrives at its May 29 earnings release with the same fundamental split that has defined this entire preview cycle — except the short side has just re-escalated sharply. The borrow market…
Dr. Reddy's Laboratories arrives at its May 25 earnings release with two positioning camps — one in the options market, one in the lending pool — refusing to give ground to the other. The borrow market remains the more…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RDY — free to start on ORTEX.
Sign up for free →Open RDY on ORTEX